Hemophilia
📧 Sign up to get email alerts when something new happens for Hemophilia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-09-17Clinical Trial Update: Pegasys® Plus Ribavirin in Hemophilic Patients With Hepatitis C Virus Infection [Phase 4]
A Phase 4 trial evaluating Pegasys (pegylated interferon alfa-2a) plus ribavirin in hemophilic patients with hepatitis C has completed. The …
-
CLINICAL_TRIALS trial_result · 2009-08-21Clinical Trial Update: Study Evaluating rFIX; BeneFIX® in Hemophilia B [Phase 3]
A Phase 3 trial evaluating BeneFIX (recombinant factor IX) for Hemophilia B has completed.
-
CLINICAL_TRIALS trial_result · 2009-07-20Clinical Trial Update: Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery [Phase 3]
This clinical trial update reports the completion of a Phase 3 study evaluating B-domain deleted recombinant factor VIII (BDDrFVIII), market…
-
CLINICAL_TRIALS trial_result · 2009-07-02Clinical Trial Update: A Feasibility Study to Collect Data in Patients With Haemophilia
AstraZeneca completed a feasibility clinical trial designed to collect data in patients with hemophilia.
-
CLINICAL_TRIALS trial_result · 2009-06-30Clinical Trial Update: International PMS Study - KOGENATE Bayer
Clinical trial update for KOGENATE Bayer indicates the International PMS Study has completed in Hemophilia A.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-03-27FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Meitheal Pharmaceuticals Inc.)
FDA approved a supplemental application for Desmopressin Acetate submitted by Meitheal Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2008-11-25Clinical Trial Update: Efficacy and Safety of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With Hemophilia
A clinical trial update reporting on the efficacy and safety of MK-0518 (raltegravir) in treatment-experienced HIV-1 infected adults with he…
-
CLINICAL_TRIALS trial_result · 2008-09-19Clinical Trial Update: The Use of Cyclokapron for Treatment and Management of Women With Bleeding Disorders [NA]
Clinical trial update reports completion of a study on the use of Cyclokapron (tranexamic acid) for treatment and management of bleeding dis…
-
FDA approval · 2008-09-03FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Desmopressin Acetate from Apotex Corp., indicating an addition or modification to the approved p…
-
CLINICAL_TRIALS trial_result · 2008-07-30Clinical Trial Update: Treatment of Hepatitis C in Hemophilic Patients With HIV [Phase 2]
A completed Phase 2 clinical trial evaluated treatment for Hepatitis C in patients with HIV infection and hemophilia.
-
FDA label_change · 2008-04-25FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Bauch & Lomb Incorporated)
FDA approved a supplemental application for Desmopressin Acetate from Bauch & Lomb Incorporated, indicating changes to labeling or related r…
-
CLINICAL_TRIALS trial_result · 2008-04-22Clinical Trial Update: Study Evaluating BDDRFVIII and ReFacto AF in Hemophilia A [Phase 3]
Phase 3 clinical trial evaluating BDDRFVIII and ReFacto AF in patients with Hemophilia A has completed.
-
CLINICAL_TRIALS trial_result · 2008-04-22Clinical Trial Update: Study to Establish Bioequivalence of ReFacto AF (BDDrFVIII) With Advate (FLrFVIII) in Hemophilia A [Phase 3]
Phase 3 trial completed to establish bioequivalence between ReFacto AF and Advate for Hemophilia A.
-
CLINICAL_TRIALS trial_result · 2008-04-22Clinical Trial Update: Study Evaluating ReFacto AF in Severe Hemophilia A [Phase 3]
Phase 3 study evaluating ReFacto AF in severe Hemophilia A has completed.
-
FDA approval · 2008-03-11FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Desmopressin Acetate from Apotex Corp., updating the approved generic product. The action formal…
-
CLINICAL_TRIALS trial_result · 2007-12-28Clinical Trial Update: Study Evaluating ReFacto® in Hemophilia A Undergoing Major Surgery [Phase 4]
A Phase 4 study evaluating ReFacto for Hemophilia A patients undergoing major surgery has completed.
-
CLINICAL_TRIALS trial_result · 2007-12-27Clinical Trial Update: Study Evaluating rFIX; BeneFIX in Severe Hemophilia B [Phase 3]
The Phase 3 trial evaluating BeneFIX (recombinant coagulation factor IX) for severe Hemophilia B has completed. The update confirms study co…
-
CLINICAL_TRIALS trial_result · 2007-12-27Clinical Trial Update: Study Evaluating BENEFIX in Previously Treated Patients With Hemophilia B [Phase 4]
Phase 4 study of BENEFIX in previously treated patients with Hemophilia B has completed.
-
CLINICAL_TRIALS trial_result · 2007-12-27Clinical Trial Update: Study Evaluating Approach to Treatment of Haemophilia A and B in Spain
The trial evaluating approaches to treating Hemophilia A and Hemophilia B in Spain has completed, with Wyeth now a wholly owned subsidiary o…
-
CLINICAL_TRIALS trial_result · 2007-12-05Clinical Trial Update: Study Evaluating of Recombinant Human Factor IX (BeneFIX) and a New Formulation of BeneFIX (rFIX-R) in Moderate to Severe Hemophilia B [Phase 3]
Phase 3 trial update evaluating BeneFIX and a new BeneFIX formulation (rFIX-R) in moderate to severe Hemophilia B has completed.
-
CLINICAL_TRIALS research · 2007-12-05Clinical Trial Update: Study to Describe the Allergic Reactions to Factor IX in Patients With Hemophilia B
A completed clinical trial update describing allergic reactions to Factor IX in patients with Hemophilia B.
-
FDA approval · 2007-10-26FDA Approved: DDAVP — Supplemental Application (Ferring Pharmaceuticals Inc.)
FDA approved a supplemental application for DDAVP (desmopressin acetate) from Ferring Pharmaceuticals Inc., updating the product's labeling.
-
CLINICAL_TRIALS trial_result · 2007-10-04Clinical Trial Update: Study of Recombinant Porcine Factor VIII (FVIII) in Hemophilia and Inhibitors to FVIII [Phase 2]
A Phase 2 clinical trial evaluating recombinant porcine factor VIII for patients with Hemophilia A and inhibitors to factor VIII has complet…
-
CLINICAL_TRIALS trial_result · 2007-08-30Clinical Trial Update: Post Marketing Study in Haemophilia B Patients Using Nonafact® (Human Coagulation Factor IX) [Phase 4]
Phase 4 post-marketing study of Nonafact (human coagulation factor IX) in patients with Hemophilia B has completed. The trial status is COMP…
-
EMA trial_result · 2007-07-31EMEA completes the review of recombinant factor VIII products and inhibitor development
EMA completes review of recombinant factor VIII products and inhibitor development, focusing on safety and immunogenicity concerns related t…